Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2026-02-22 @ 5:24 PM
Study NCT ID:
NCT02265666
Status:
COMPLETED
Last Update Posted:
2014-10-16
First Post:
2014-10-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Relative Bioavailability, Safety and Tolerability of Two Tablet Formulations of BIIL 284 BS
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-10
Start Date Type:
None
Primary Completion Date:
2001-11
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2014-10-15
First Submit QC Date:
None
Study First Post Date:
2014-10-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-10-15
Last Update Post Date:
2014-10-16
Last Update Post Date Type:
ESTIMATED